Home/Filings/4/0000950170-24-133231
4//SEC Filing

WINDSOR JAMES BRIAN 4

Accession 0000950170-24-133231

CIK 0001420565other

Filed

Dec 3, 7:00 PM ET

Accepted

Dec 4, 4:05 PM ET

Size

5.4 KB

Accession

0000950170-24-133231

Insider Transaction Report

Form 4
Period: 2024-12-02
WINDSOR JAMES BRIAN
President and COO
Transactions
  • Award

    Stock Option (right to buy)

    2024-12-02+517,500517,500 total
    Exercise: $2.85Exp: 2034-12-01Common Stock (517,500 underlying)
Footnotes (1)
  • [F1]This option was granted on December 2, 2024. The shares underlying the option are scheduled to vest as of 25% of the shares on December 2, 2025 and thereafter in equal monthly installments through December 2, 2028.

Documents

1 file

Issuer

Aileron Therapeutics, Inc.

CIK 0001420565

Entity typeother

Related Parties

1
  • filerCIK 0001790933

Filing Metadata

Form type
4
Filed
Dec 3, 7:00 PM ET
Accepted
Dec 4, 4:05 PM ET
Size
5.4 KB